Keywords
Affiliated Institutions
Related Publications
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the ...
A Taxpayer-Funded Clinical Trials Registry and Results Database
It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Importance The mean cost of developing a new drug has been the subject of debate, with recent estimates ranging from $314 million to $2.8 billion. Objective To estimate the rese...
Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo
Antibiotic resistance is projected as one of the greatest threats to human health in the future and hence alternatives are being explored to combat resistance. Antimicrobial pep...
Clinical End Points in Coronary Stent Trials
Background— Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of asse...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 3
- Issue
- 1
- Pages
- 118-118
- Citations
- 992
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1038/s41746-020-00324-0